Table 1 Patient characteristics and follow up.
N | ||
|---|---|---|
Male—N (%) | 1436 | 900 (62.7%) |
Birth year—median [IQR] | 1944 [1939, 1949] | |
Age at baseline—median [IQR] | 72 [66, 77] | |
Age at onset—median [IQR] | 1256 | 65 [57, 71] |
Age at diagnosis—median [IQR] | 1317 | 67 [59, 73] |
Years since onset—median [IQR] | 1256 | 6.2 [3.7, 10.7] |
Years since diagnosis—median [IQR] | 1317 | 4.2 [1.6, 8.6] |
Relatives with PD—N (%) | 1251 | 238 (19.0%) |
Levodopa treatment at baseline—N (%) | 1436 | 1301 (90.6%) |
Levodopa-naïve at baseline—N (%) | 1436 | 58 (4.0%) |
Hoehn and Yahr score at baseline—N (%) | 1320 | |
No signs of disease | 10(0.8%) | |
Unilateral involvement only | 3022.9%) | |
Unilateral and axial involvement | 1370.4%) | |
Bilateral involvement without impairment of balance | 2821.4%) | |
Mild bilateral disease with recovery on pull test | 193 (14.6%) | |
Mild to moderate bilateral disease; some postural instability; physically independent | 251 (19.0%) | |
Severe disability; still able to walk or stand unassisted | 77 (5.8%) | |
Wheelchair bound or bedridden unless aided | 22 (1.7%) | |
Number of visits—median [IQR] | 1436 | 2 [1, 3] |
Patients with only baseline visit—N (%) | 516 (36%) | |
Follow up time—mean [SD] | 1.7 [2.2] |
